English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/19636
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Abnormal and normal N-heterocyclic carbene osmium polyhydride complexes obtained by direct metalation of imidazolium salts

AuthorsEguillor, Beatriz ; Esteruelas, Miguel A. ; Oliván, Montserrat ; Puerta, Marta
Issue Date16-Jan-2008
PublisherAmerican Chemical Society
CitationOrganometallics 27(3): 445–450 (2008)
AbstractThe complex OsH6(PiPr3)2 (1) is a basic precursor which promotes the direct metalation of imidazolium salts. Thus, it reacts with 1-mesityl-3-methylimidazolium tetraphenylborate and 1-mesityl-3-ethylimidazolium tetraphenylborate to give the abnormal NHC derivatives [OsH5(1-mesityl-3-methylimidazol-4-ylidene)(PiPr3)2]BPh4 (2) and [OsH5(1-mesityl-3-ethylimidazol-4-ylidene)(PiPr3)2]BPh4 (3), respectively. Treatment of 2 and 3 with NaH produces the deprotonation of the metal center and the formation of the tetrahydride derivatives OsH4(1-mesityl-3-methylimidazol-4-ylidene)(PiPr3)2 (4) and OsH4(1-mesityl-3-ethylimidazol-4-ylidene)(PiPr3)2 (5). In contrast to the case for the mesityl-substituted imidazolium salts, the reaction with 1-benzyl-3-methylimidazolium tetraphenylborate leads to the normal NHC complex [OsH5(1-benzyl-3-methylimidazol-2-ylidene)(PiPr3)2]BPh4 (6). The deprotonation of 6 with NaH affords OsH4(1-benzyl-3-methylimidazol-2-ylidene)(PiPr3)2 (7). Complexes 2 and 4 have been characterized by X-ray diffraction analysis.
Description6 pages, 4 figures, 1 table, 2 schemes.
Publisher version (URL)http://dx.doi.org/10.1021/om7010722
Appears in Collections:(ICMA) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.